Shiseido has agreed to sell its entire interest in Shiseido Liyuan Cosmetics Co., Ltd (SLC), the China-only Aupres business, to a consortium led by IDG Capital. The company said on 17 November 2026 that it had decided on the sale that day and signed a legally binding equity transfer agreement with the buyers, plus a legally binding transition services agreement with SLC.
The sale covers Aupres and the SLC business, including its Beijing factory and production equipment. Shiseido said its China and travel retail business will carry on, with resources going to focus brands, brand portfolio strengthening, research and development, new growth areas and digital and AI use.
Who is buying
The buyer is a three-part consortium: two special purpose vehicles set up by funds that IDG manages, and a limited partnership formed by SLC's incoming management team. Shiseido did not name the limited partners behind the two partnerships.
| Buyer | Structure | Stake |
|---|---|---|
| Sunrise Winning Limited | Cayman Islands vehicle of a US dollar fund, wholly owned by IDG Breyer Capital Fund L.P. | 80.66% |
| Zhuhai Pulai Management Consulting Partnership (Limited Partnership) | Limited partnership set up by a China-based renminbi fund | 14.34% |
| Shanghai Bozhiyuan Enterprise Management Partnership (Limited Partnership) | Limited partnership formed by SLC's new management team | 5.00% |
The two vehicles would receive a combined 95% of the stake, the figure Shiseido gives, and the management partnership 5%. The Cayman Islands vehicle, Sunrise Winning Limited, was set up on 3 September 2026 and is wholly owned by IDG Breyer Capital Fund L.P. The Zhuhai partnership was formed on 29 October 2026, and the management partnership on 20 October 2026. Shiseido says it has no capital, personnel or trading relationship with any of the three, and none is a related party.
What is being sold
SLC was set up in 1991 as a joint venture with Beijing Liyuan, a company under the Beijing municipal government-linked Yiqing Group, and has made and sold Aupres cosmetics since 1994. The third joint-venture contract expires in December 2026. The two sides agreed to end the partnership on expiry, and on 1 September 2026 the Shiseido group bought Beijing Liyuan's 35% stake. Shiseido now describes SLC as 100% group-owned.
In the year to December 2025 SLC, reporting under IFRS, had sales of RMB868mn (¥18.08bn) and an operating loss of RMB55mn (¥1.16bn). Its loss attributable to the parent was RMB41mn (¥860mn). At the end of 2025 it had total assets of RMB900mn (¥20.19bn) and equity of RMB618mn (¥13.88bn).
Terms and timing
Shiseido did not disclose the price, citing confidentiality obligations in the transfer agreement. It said the figure followed due diligence and arm's-length negotiation between the parties.
Shiseido's stated rationale is that SLC needs continued investment in product innovation and digital capability, and that after weighing the business's sustainability and its own investment priorities, handing it to IDG was the best option. It describes IDG as an international private equity firm with deep consumer-sector experience.
To smooth the handover, Shiseido will license certain intellectual property needed to run the business. For a period after the sale it will also support new product development, provide technical help to keep existing products in stable supply, and keep supplying raw materials and some products.
Completion depends on approvals from the relevant authorities, including in China, and other customary closing conditions. Shiseido expects the transfer to complete between the fourth quarter of 2026 and the first quarter of 2027. It said the approximate effect on its December 2026 consolidated results is already in the full-year forecast revision it published on 10 November.
